GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M
Jul 4th 2008Drug InformationMedicare / Medicaid / Tricare
An Alabama state court jury on Tuesday found pharmaceutical companies GlaxoSmithKline and Novartis guilty of defrauding the state Medicaid program by charging artificially high prices for medications and ordered the two companies to pay more than $114 million in restitution, the
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
